DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Stifel Maintains Buy on Spero Therapeutics, Lowers Price Target to $21

Stifel maintains Spero Therapeutics (NASDAQ:SPRO) with a Buy and lowers the price target from $22 to $21.

Benzinga · 03/17/2020 14:10

Stifel maintains Spero Therapeutics (NASDAQ:SPRO) with a Buy and lowers the price target from $22 to $21.